Omzo's program is cash-pay and does not accept Medicare, Medicaid, or commercial insurance
Existing data suggest that the effects of GLP-1 on adipose tissue are primarily indirect
These disorders can be associated with insulin resistance, hyperglycemia-induced damage, oxidative stress, astrocyte abnormalities, and mitochondrial dysfunction, resulting in insufficient energy supply, altered synaptic plasticity, death of neuronal cells, as well as functional and structural damage to reward networks
not FDA-approved) use that aims to achieve the therapeutic benefits of the medication, including appetite suppression and improved metabolic health, while significantly reducing the risk and severity of common side effects, which can include issues like bloating, diarrhea, nausea, vomiting, and more